Skip to content

Reverse Total Shoulder Arthroplasty in Patients Who Exceeded Their Life-expectancy: a Retrospective Study

Reverse Total Shoulder Arthroplasty in Patients Who Exceeded Their Life-expectancy: a Retrospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04807322
Enrollment
110
Registered
2021-03-19
Start date
2019-03-24
Completion date
2020-12-21
Last updated
2021-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reverse Total Shoulder Arthroplasty

Keywords

reverse total shoulder arthroplasty, RTSA, elderly, proximal humerus fracture, cuff arthropathy, outcome, complications

Brief summary

Reverse total shoulder arthroplasty (RTSA) has become an established treatment for cuff arthropathy, severe osteoarthritis and in certain fracture cases. Due to the increasingly aging population, patients who have already exceeded their life-expectancy pose a significant challenge to the shoulder surgeon. Therefore, we wanted to investigate patient demographics, hospital stay length, complication rate functional outcome, patient reported outcome scores and mortality retrospectively for patients, who were older than 83 years at time of implantation of a RTSA.

Detailed description

This is a retrospective single institution study. All patients older than 83 years who received a reverse shoulder arthroplasty from 2008 until 2019 are included. Elective cases are compared to fracture cases (patient demographics, length of hospital stay, complication rate, functional outcome, patient reported outcome scores and mortality).

Interventions

Implantation of a Reverse Total Shoulder Arthroplasty

Sponsors

Bürgerspital Solothurn
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
83 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients older than 83 years at time of surgery * Patients who received a reverse total shoulder arthroplasty

Exclusion criteria

* Patients younger than 83 years at time of surgery

Design outcomes

Primary

MeasureTime frameDescription
Quality adjusted life year (QALY)until august 2020The quality adjusted life year (QALY) ) is a well-established indicator of the life quality for the remaining years and was calculated as the years of life following the operation, multiplied by the utility value, for the current study, defined as the postoperative American Shoulder and Elbow Surgeons Shoulder Score (ASES) score (0-1 points) at last follow-up.
Patient reported outcome score: ASESuntil august 2020American Shoulder and Elbow Society (ASES) Score
Complication rateuntil august 2020postoperative complications requiring surgical intervention
Patient reported outcome score: VASuntil august 2020Visual analog score (VAS)
Mortalityuntil august 2020Survivership
Patient reported outcome score: QuickDASHuntil august 2020Quick Disabilities of the arm, shoulder and hand (DASH) Score,

Secondary

MeasureTime frameDescription
Patient demographicsat time of surgerymale/female ratio, age, BMI, ASA (American Society of Anesthesiologists) classification, hospital stay length, range of motion

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026